Management of COPD with Influenza in Hospital Setting
Introduction to Management
- The American Thoracic Society recommends initiating oseltamivir 75 mg orally twice daily for 5 days, systemic corticosteroids, short-acting bronchodilators, and antibiotics to address the acute exacerbation in hospitalized COPD patients with influenza 1
Antiviral Therapy
- Start oseltamivir immediately if the patient presents within 48 hours of symptom onset, with fever, and has acute influenza-like illness 2, 1
- The standard adult dose is 75 mg orally twice daily for 5 days 2, 1
- Reduce the dose by 50% if creatinine clearance is less than 30 mL/minute 2
- Oseltamivir reduces illness duration by approximately 24 hours and may reduce hospitalization rates 2
Systemic Corticosteroids
- Systemic corticosteroids improve lung function, oxygenation, and shorten recovery time and hospitalization duration in COPD exacerbations 1
- Prednisone 40 mg daily for 5 days is the recommended regimen 1
Bronchodilator Therapy
- Initiate short-acting inhaled β2-agonists with or without short-acting anticholinergics as first-line bronchodilator treatment 1
- Continue or initiate long-acting bronchodilators as soon as possible, ideally before hospital discharge 1
Antibiotic Coverage
- Co-amoxiclav is first-line because it covers common secondary bacterial pathogens 2, 1
- Doxycycline is an alternative for patients intolerant of beta-lactams 2, 1
- Avoid macrolides as first-line therapy due to antimicrobial resistance concerns and inferior coverage of H. influenzae 2, 1
Oxygen Management
- Assess oxygen saturation immediately and maintain SpO2 ≥92% 1, 4
- For patients with known COPD and potential CO2 retention, start with controlled oxygen and titrate based on repeated arterial blood gas measurements 1, 4
Severity Assessment and Monitoring
- Calculate CURB-65 score to determine pneumonia severity 3, 4
- Check vital signs at least twice daily 1, 4
ICU/HDU Transfer Criteria
- Transfer to intensive care if failing to maintain SpO2 >92% despite FiO2 >60%, severe respiratory distress, or hemodynamic instability 4